Comparison of the Direct Oral Anticoagulants and Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials

Comparison of the Direct Oral Anticoagulants and Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials

Background: Direct oral anticoagulants (DOACS) are approved for use in non-valvular atrial fibrillation (AF). This systematic review and meta-analysis aimed to evaluate the efficacy and safety of DOACs vs. warfarin and update the evidence for treatment of AF and valvular heart disease (VHD).Methods:...

Full description

Bibliographic Details
Main Authors: Yasmin de Souza Lima Bitar, Andre Rodrigues Duraes, Leonardo Roever, Mansueto Gomes Neto, Liliane Lins-Kusterer, Edimar Alcides Bocchi
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-09-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
valvular atrial fibrillation
valvular heart disease
warfarin
direct oral anticoagulants
anticoagulation
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2021.712585/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2021.712585/full

Similar Items